Financhill
Back

TScan Therapeutics 10K Form

Sell
43

TCRX
TScan Therapeutics

Last Price:
$1.81
Seasonality Move:
-22.79%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive TCRX News And Ratings

See the #1 stock for the next 7 days that we like better than TCRX

TCRX Financial Statistics

Sales & Book Value

Annual Sales: $2.8M
Cash Flow: $-39.1M
Price / Cash Flow: 0
Annual Sales: $3.71
Price / Book: 0.45

Profitability

EPS (TTM): -1.09000
Net Income (TTM): $-131.5M
Gross Margin: --
Return on Equity: -62.11%
Return on Assets: -39.42%

TScan Therapeutics Earnings Forecast

Key TScan Therapeutics Financial Ratios

  • The Research & Development expenses have been 3,812.14% of Revenue.
  • The Net Earning history of TCRX is -4,527.66% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 3 years.

TScan Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: TCRX
Website: tscan.com

Debt

Debt-to-Equity Ratio: 0.15
Current Ratio: 8.55
Quick Ratio: 8.44

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

TCRX Technical Analysis vs Fundamental Analysis

Sell
43
TScan Therapeutics (TCRX) is a Sell

Is TScan Therapeutics a Buy or a Sell?